At WoundCon Fall, Jeanine Maguire, PhD, MPT, CWS introduced the use of electrical stimulation (e-stim) as a modality in wound healing. She discussed key terminology, current parameters for use in the United States, and important considerations for all clinicians.
Dr. Maguire began by pointing out that e-stim is best known as a modality in physical therapy to promote physiologic tissue healing in musculoskeletal injury. She said she approaches e-stim in wound management with a similar mindset. Many national and international organizations support electrical stimulation for wounds. Specifically, the Centers for Medicare and Medicaid Services cites its appropriateness for select types of wounds that have not responded to standard wound care over at least 30 days.1
Dr. Maguire stressed that before choosing electrical stimulation, it is important to assure proper evaluation of the wound etiology and the reasons for nonhealing. She said this may include:
Exploration of the role of chronic disease and relevant social determinants of health is also wise, she noted.
When used in wound management, Dr. Maguire shared that e-stim allows an electric current to pass through the wound. This current promotes angiogenesis, collagen production, and migration of epithelium.2 It is applied via electrodes placed on the skin in close proximity to the wound. She related that this is usually just around the wound, allowing one to not disturb the dressing. There are multiple settings to consider, so she encouraged clinicians to consult with unit manufacturers to understand the nuances of each specific device.
Dr. Maguire then presented the concept of looking at the skin as a battery. Accordingly, when there is a break in the skin, this represents a “short circuiting” of the transepithelial voltage, causing a voltage difference between that wound and the surrounding skin.3 Electrical stimulation attempts to restore that break in current.
Antibacterial Impact. Multiple in vitro studies found that e-stim had an antibacterial effect, especially when using positive polarity, high-voltage pulsed current (HVPC), and silver anodes.4-7
Improving Healing. A 2021 review of 30 randomized controlled trials (RCTs) on e-stim in wound care found acceleration of wound healing with potential for increased epithelialization, increased local vascularity, reduced pain, increased fibroblast migration, and less financial burden.3 Several other studies noted improvement in healing for venous wounds and pressure injuries.8-10
Perfusion. Evaluation of 2 series of cases involving limb ischemia found improvements in the transcutaneous oxygen pressure (TcPO2) of the associated wounds with e-stim as part of treatment.11
Phases of Wound Healing. Three RCTs of human punch biopsies using direct current electrical stimulation looked at the proliferative phase of healing and found increases in growth factors, angiogenesis, and granulation tissue while resulting in decreased wound size.12 Additionally, case studies examining the remodeling phase found increased fibroblastic activity in wounds with electrical stimulation.13
Pain Management. A series of cases involving several wound etiologies found that 12 days using wearable microcurrent electrical stimulation resulted in 100% pain reduction over the treatment period, improving as the treatment period progressed.14
Impairment of the Skin “Battery”. The research also shows that age and diabetes are factors that impair the current of skin injury. E-stim therapy has the potential to initiate a “kick-start” of that battery.15-17
Dr. Maguire shared that clinicians should be aware of the potential contraindications and precautions associated with electrical stimulation of wounds. Among these are:
Risks of electrical stimulation are low, with possible skin irritation being a consideration. However, she stressed the importance of reviewing potential contraindications for each patient use.
From a practice management perspective, Dr. Maguire noted that it is vital to be aware of your local practice act and any other relevant state or federal laws that could influence the ability to use e-stim. It is also important to investigate the reimbursement structure in your area and through your payors. It is important to note that TENS/microcurrent (transcutaneous electrical nerve stimulation) is different from e-stim as discussed in this presentation, and it may not be reimbursable for wounds.
Dr. Maguire conveyed that she hopes clinicians will remember the potential positive benefits in wound healing and pain management provided by e-stim. The relatively low risk, ease of use, and low cost make it an appealing option for the right patients. She noted that additional research could provide clearer treatment parameters and standardization of its use in wound management.
Overall, she advised addressing the cause of the wound, the cause of the non-healing, and to implement standard wound care before utilizing e-stim. Clinicians should assess if e-stim is possible for the patient, if one is competent and comfortable with its use, and any risks to the patient. Finally, she noted that wound care providers can look at e-stim as a possible “jump-start” adjunctive treatment for chronic, full-thickness wounds not progressing towards healing.
References
The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, HMP Global, its affiliates, or subsidiary companies.